Tactiva Therapeutics is an immuno-oncology company specializing in potent cancer immunotherapy using a dual T cell receptor approach.
View Top Employees from Tactiva TherapeuticsWebsite | https://tactivatherapeutics.com |
Revenue | $8 million |
Funding | $35 million |
Employees | 5 (1 on RocketReach) |
Founded | 2016 |
Address | 701 Ellicott St 4th Floor, Buffalo, New York 14203, US |
Phone | (716) 536-2971 |
Industry | Biotechnology Research, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering |
SIC | SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541711 Companies |
Looking for a particular Tactiva Therapeutics employee's phone or email?
The Tactiva Therapeutics annual revenue was $8 million in 2024.
1 people are employed at Tactiva Therapeutics.
Tactiva Therapeutics is based in Buffalo, New York.
The NAICS codes for Tactiva Therapeutics are [541, 5417, 54171, 54, 541711].
The SIC codes for Tactiva Therapeutics are [28, 80, 283].